Chinese Journal of Dermatology ›› 2023, e20230193.doi: 10.35541/cjd.20230193
• Reviews • Previous Articles Next Articles
Hu Ying, Jiao Qingqing
Received:
2023-04-07
Revised:
2023-06-12
Online:
2023-01-05
Published:
2023-09-04
Contact:
Jiao Qingqing
E-mail:qingqingjiao@suda.edu.cn
Supported by:
Hu Ying, Jiao Qingqing. Memory T cells in chronic autoimmune skin diseases[J]. Chinese Journal of Dermatology,2023,e20230193. doi:10.35541/cjd.20230193
[1] | Boniface K, Jacquemin C, Darrigade A S, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3 [J]. J Invest Dermatol, 2018,138(2):355⁃364. doi: 10.1016/j.jid.2017.08.038. |
[2] | Chen L, Shen Z. Tissue⁃resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders[J]. Cell Mol Immunol, 2020,17(1):64⁃75. doi: 10. 1038/s41423⁃019⁃0291⁃4. |
[3] | Cheuk S, Schlums H, Gallais Sérézal I, et al. CD49a expression defines tissue⁃resident CD8(+) T cells poised for cytotoxic function in human skin[J]. Immunity, 2017,46(2):287⁃300. doi: 10.1016/j.immuni.2017.01.009. |
[4] | Kurihara K, Fujiyama T, Phadungsaksawasdi P, et al. Signifi⁃cance of IL⁃17A⁃producing CD8(+)CD103(+) skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course[J]. J Dermatol Sci, 2019,95(1):21⁃27. doi: 10.1016/j.jdermsci.2019.06.002. |
[5] | Lee Y J, Park J A, Kwon H, et al. Role of stem cell⁃like memory T cells in systemic lupus erythematosus[J]. Arthritis Rheumatol, 2018,70(9):1459⁃1469. doi: 10.1002/art.40524. |
[6] | Fazeli P, Talepoor AG, Faghih Z, et al. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes[J]. Immun Inflamm Dis, 2022,10(10):e715. doi: 10.1002/iid3.715. |
[7] | Ryan GE, Harris JE, Richmond JM. Resident memory T cells in autoimmune skin diseases[J]. Front Immunol, 2021,12:652191. doi: 10.3389/fimmu.2021.652191. |
[8] | Hosokawa K, Muranski P, Feng X, et al. Memory stem T cells in autoimmune disease: high frequency of circulating CD8+ memory stem cells in acquired aplastic anemia [J]. J Immunol, 2016,196(4):1568⁃1578.doi:10.4049/jimmunol.1501739. |
[9] | Hadi A, Wang JF, Uppal P, et al. Comorbid diseases of vitiligo: a 10⁃year cross⁃sectional retrospective study of an urban US population[J]. J Am Acad Dermatol, 2020,82(3):628⁃633. doi: 10.1016/j.jaad.2019.07.036. |
[10] | Lin F, Sun X, Lei J, et al. Altered circulating memory T cells in vitiligo cases followed NB⁃UVB therapy[J]. Photodermatol Photoimmunol Photomed, 2022,38(1):76⁃82. doi: 10.1111/phpp. 12719. |
[11] | Martins C, Darrigade AS, Jacquemin C, et al. Phenotype and function of circulating memory T cells in human vitiligo[J]. Br J Dermatol, 2020,183(5):899⁃908. doi: 10.1111/bjd.18902. |
[12] | Fujiyama T, Umayahara T, Kurihara K, et al. Skin infiltration of pathogenic migratory and resident T cells is decreased by secukinumab treatment in psoriasis[J]. J Invest Dermatol, 2020,140(10):2073⁃2076.e6. doi: 10.1016/j.jid.2020.02.024. |
[13] | Kasprowicz⁃Furmańczyk M, Czerwińska J, Placek W, et al. Assessment of the tissue resident memory cells in lesional skin of patients with psoriasis and in healthy skin of healthy volunteers[J]. Int J Environ Res Public Health, 2021,18(21)doi: 10.3390/ijerph182111251. |
[14] | Phadungsaksawasdi P, Fujiyama T, Kurihara K, et al. PD⁃1 expression defines epidermal CD8(+)CD103(+) T cells preferentially producing IL⁃17A and using skewed TCR repertoire in psoriasis[J]. J Invest Dermatol, 2021,141(10):2426⁃2435.e5. doi: 10.1016/j.jid.2021.03.011. |
[15] | Suzuki K, Suzuki K, Yabe Y, et al. NF⁃κB1 contributes to imiquimod⁃induced psoriasis⁃like skin inflammation by inducing Vγ4(+)Vδ4(+)γδT17 cells[J]. J Invest Dermatol, 2022,142(6):1639⁃1649.e5. doi: 10.1016/j.jid.2021.11.004. |
[16] | Zhao Z, Zhu H, Li Q, et al. Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases[J]. J Autoimmun, 2022,128:102811. doi: 10.1016/j.jaut.2022.102811. |
[17] | Gu HJ, Song S, Roh JY, et al. Expression pattern of tissue⁃resident memory T cells in cutaneous lupus erythematosus[J]. Lupus, 2021,30(9):1427⁃1437. doi: 10.1177/09612033211017218. |
[18] | 袁祥, 周滢波, 王其凯,等. 系统性红斑狼疮组织原位记忆T细胞表达与皮损相关性研究[J]. 中华风湿病学杂志, 2017,21(10):680⁃684,722. doi: 10.3760/cma.j.issn.1007⁃7480.2017.10. 007. |
[19] | Chen X, Guo W, Chang Y, et al. Oxidative stress⁃induced IL⁃15 trans⁃presentation in keratinocytes contributes to CD8(+) T cells activation via JAK⁃STAT pathway in vitiligo[J]. Free Radic Biol Med, 2019,139:80⁃91. doi: 10.1016/j.freeradbiomed. 2019.05.011. |
[20] | Richmond JM, Strassner JP, Zapata L, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo[J]. Sci Transl Med, 2018,10(450):eaan7710. doi: 10.1126/scitranslmed.aam7710. |
[21] | Martins C, Migayron L, Drullion C, et al. Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through Jak signaling[J]. J Invest Dermatol, 2022,142(4):1194⁃1205.e7. doi: 10.1016/j.jid.2021.09.015. |
[22] | Azzolino V, Zapata L Jr, Garg M, et al. Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells[J]. J Invest Dermatol, 2021,141(1):182⁃184.e1. doi: 10.1016/j.jid.2020.04.027. |
[23] | Song H, Hu Z, Zhang S, et al. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real⁃world clinical practice[J]. Dermatol Ther, 2022,35(11):e15821. doi: 10.1111/dth.15821. |
[24] | Mehta H, Mashiko S, Angsana J, et al. Differential changes in inflammatory mononuclear phagocyte and T⁃cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab[J]. J Invest Dermatol, 2021,141(7):1707⁃1718.e9. doi: 10. 1016/j.jid.2021.01.005. |
[25] | Chen Y, Yan Y, Liu H, et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T⁃cell memory in wild⁃type and humanized mice[J]. Theranostics, 2020,10(23):10466⁃10482. doi: 10.7150/thno.45211. |
[26] | Pan Y, Tian T, Park C O, et al. Survival of tissue⁃resident memory T cells requires exogenous lipid uptake and metabolism [J]. Nature, 2017,543(7644):252⁃256. doi: 10.1038/nature21379. |
[1] | Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2024, 57(5): 479-482. |
[2] | Zhang Yuanwen, Sun Congqian, Pan Wendong. Off-label clinical application of botulinum toxin in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(5): 471-475. |
[3] | Hu Mengyao, Li Min, Chen Sihan, Wei Xuecui, Chen Yujie, Xu Song, Chen Xu, . Different regulatory effects of S100A8/A9 expressed by keratinocytes in three common inflammatory skin injury modes [J]. Chinese Journal of Dermatology, 2024, 57(5): 435-444. |
[4] | China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417. |
[5] | Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354. |
[6] | Ye Hui, Xue Rujun, Zhang Xibao. Application of biological therapies and mechanisms of immunophenotypic switching in psoriasis and atopic dermatitis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220795-e20220795. |
[7] | Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578. |
[8] | Wang Yukun, Liu Jie. Application of deep learning in non-neoplastic dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220660-e20220660. |
[9] | Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274. |
[10] | Chen Xingyu, Yao Xu. Role of neutrophils in inflammatory dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220865-e20220865. |
[11] | Wu Yubing, Wang Xiaoyu, An Binyi, Wu Yingying, Sang Hong, Kong Qingtao, . Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes signaling pathway in the occurrence of psoriasis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230394-e20230394. |
[12] | Zhu Tingting, Zhang Xuejun. Apremilast in the treatment of plaque psoriasis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230448-e20230448. |
[13] | Hao Dan, Wang Yiyi, Xiao Yue, Yan Wei, Li Wei. Systemic treatment options for psoriasis in special areas [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230190-e20230190. |
[14] | Sun Weiwei, Chen Jianru, Li Shuli, Gao Tianwen, Li Chunying . Analysis of depression-like behavioral performances of mouse models of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(2): 147-154. |
[15] | Dou Jinfa, Wang Jianbo, Zhang Shuai, Li Jianguo, Liu Hongwei, Zhang Shoumin. Analysis of disease progression and influencing factors in patients with moderate to severe plaque psoriasis receiving biologic therapy during the coronavirus disease 2019 pandemic: a single-center cross-sectional study [J]. Chinese Journal of Dermatology, 2024, 0(2): 20230167-e20230167. |
|